Shifting paradigms of antiplatelet therapy: Assessing new drugs versus old

被引:0
|
作者
Gonzalez, ER [1 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA 23298 USA
关键词
D O I
10.1093/ajhp/55.suppl_1.S3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S3 / S3
页数:1
相关论文
共 50 条
  • [31] Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs Introduction
    Ganapathi, Ram N.
    Ganapathi, Mahrukh K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 1 - 4
  • [32] Stroke:: antithrombin versus antiplatelet therapy
    Bednar, MM
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (02) : 355 - 369
  • [33] Antiplatelet drugs: what's new?
    Oury, Cecile
    Rahmouni, Souad
    Lancellotti, Patrizio
    M S-MEDECINE SCIENCES, 2015, 31 (8-9): : 720 - 722
  • [34] New antiplatelet drugs (Part 1)
    Sumarokov, A. B.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2011, 7 (01) : 82 - 88
  • [35] New antiplatelet drugs [Neue thrombozytenhemmstoffe]
    Spannagl M.
    Frey L.
    Der Anaesthesist, 2001, 50 (3) : 142 - 149
  • [36] Assessing the optimal strategy for dual antiplatelet therapy
    Chang, Lee
    Yeh, Robert W.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (10) : 1067 - 1069
  • [37] Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
    Hentzien, Maxime
    Owen, Andrew
    Strub-Wourgaft, Nathalie
    Perez-Casas, Carmen
    Troseid, Marius
    Calmy, Alexandra
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [38] Old and New Paradigms for IT Services Offshoring
    Popoli, Paolo
    Popoli, Arturo
    INTERNATIONAL JOURNAL OF INFORMATION SYSTEMS IN THE SERVICE SECTOR, 2009, 1 (03) : 47 - 64
  • [39] Exploring old concepts and new paradigms
    Jaber, Bertrand L.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (02): : 93 - 93
  • [40] New Paradigms of Old Psychedelics in Schizophrenia
    Mahmood, Danish
    Alenezi, Sattam K.
    Anwar, Md. Jamir
    Azam, Faizul
    Qureshi, Kamal A.
    Jaremko, Mariusz
    PHARMACEUTICALS, 2022, 15 (05)